Single dose planning for radioiodine-131 therapy of Graves’ disease

[1] Glinoer D(1987)The management of hyperthyroidism due to Graves’ disease in Europe in 1986: results of an international survey Acta Endocrinol 185 9-37

[2] Hesch D(1989)The management of hyperthyroidism due to Graves’ disease in Japan in 1988 Endocrinol Jpn 36 299-314

[3] Lagasse R(1990)Current trends in the management of Graves’ disease J Clin Endocrinol Metab 70 1518-1524

[4] Laurberg P(1999)Optimized radioiodine therapy of Graves’ disease: analysis of the delivered dose and of other possible factors affecting outcome Eur J Endocrinol 141 117-121

[5] Nagayama Y(1991)Optimal iodine-131 dose for eliminating hyperthyroidism in Graves’ disease J Nucl Med 32 411-416

[6] Izumi M(1994)Standardized radioiodine therapy in Graves’ disease: the persistent effect of thyroid weight and radioiodine uptake on outcome J Intern Med 236 507-513

[7] Nagataki S(2001)Determination of the optimal minimum radioiodine dose in patients with Graves’ disease: a clinical outcome study Eur J Nucl Med 28 1489-1495

[8] Solomon B(2001)Radioiodine treatment of hyperthyroidism- prognostic factors for outcome J Clin Endocrinol Metab 86 3611-3617

[9] Glinoer D(1993)Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 34 1638-1641

[10] Lagasse R(1985)Treratment of hyper- thyroidism with standard doses of radioiodine aiming at ablation Acta Med Scand 217 55-60

[1] Glinoer D(1987)The management of hyperthyroidism due to Graves’ disease in Europe in 1986: results of an international survey Acta Endocrinol 185 9-37

[2] Hesch D(1989)The management of hyperthyroidism due to Graves’ disease in Japan in 1988 Endocrinol Jpn 36 299-314

[3] Lagasse R(1990)Current trends in the management of Graves’ disease J Clin Endocrinol Metab 70 1518-1524

[4] Laurberg P(1999)Optimized radioiodine therapy of Graves’ disease: analysis of the delivered dose and of other possible factors affecting outcome Eur J Endocrinol 141 117-121

[5] Nagayama Y(1991)Optimal iodine-131 dose for eliminating hyperthyroidism in Graves’ disease J Nucl Med 32 411-416

[6] Izumi M(1994)Standardized radioiodine therapy in Graves’ disease: the persistent effect of thyroid weight and radioiodine uptake on outcome J Intern Med 236 507-513

[7] Nagataki S(2001)Determination of the optimal minimum radioiodine dose in patients with Graves’ disease: a clinical outcome study Eur J Nucl Med 28 1489-1495

[8] Solomon B(2001)Radioiodine treatment of hyperthyroidism- prognostic factors for outcome J Clin Endocrinol Metab 86 3611-3617

[9] Glinoer D(1993)Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 34 1638-1641

[10] Lagasse R(1985)Treratment of hyper- thyroidism with standard doses of radioiodine aiming at ablation Acta Med Scand 217 55-60